RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Thymic Carcinoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Thymic Carcinoma with Adenoid Cystic Carcinoma-Like Features.
Fuentes-Martín Álvaro et al., Archivos de bronconeumologia (17 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42892576/
- 2.
Prognostic Factors and Survival in Thymoma and Thymic Carcinoma: A Retrospective Cohort Study
Ezgi Türkoğlu et al., Cerrahpasa Medical Journal (14 October 2026)
https://doi.org/10.5152/cjm.2026.26089
- 3.
Single-cell chromatin maps of thymic carcinoma reveal a conserved malignant state and its immunosuppressive dependencies
Fang-Ping Lin et al., Communications Biology (8 October 2026)
https://doi.org/10.1038/s42003-026-11058-2
- 4.
First-line toripalimab in combination with platinum-doublet chemotherapy for advanced B3 thymoma and thymic carcinoma: an open-label prospective phase Ⅱ trial.
Zhu K et al., ESMO open (8 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42854640/
- 5.
P2.046: Targeting MCL-1 Overcomes Adaptive Resistance to PI3K Inhibition in Thymic Carcinoma
Y. Kunimatsu et al., Journal of Thoracic Oncology (1 October 2026)
https://doi.org/10.1016/j.jtho.2026.104832
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
NCT04430842 · Completed · Phase 1 · Quadriga Biosciences, Inc.
Ages 18 and over
https://clinicaltrials.gov/study/NCT04430842
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Thymic Carcinoma
Thymic carcinoma is a rare cancer that starts in the thymus, a small organ in the upper chest that is part of the immune system. It is more aggressive than the more common thymoma and is more likely to spread. Treatment usually involves surgery, radiotherapy and chemotherapy, and research into targeted and immune-based treatments is ongoing.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Thymic Carcinoma?
Thymic carcinoma is a rare cancer that starts in the thymus, a small organ in the upper chest that is part of the immune system. It is more aggressive than the more common thymoma and is more likely to spread. Treatment usually involves surgery, radiotherapy and chemotherapy, and research into targeted and immune-based treatments is ongoing.
How many clinical trials are available for Thymic Carcinoma?
RareWays currently indexes 63 clinical trials for Thymic Carcinoma, of which 13 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Thymic Carcinoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Thymic Carcinoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.